Logan, a 28-year-old teacher from Iowa, told Hunterbrook Media he had been denied access to GLP-1 drugs by insurance four times even though he had been prescribed Wegovy by a doctor
In fact, the pace of regain was nearly four times faster, regardless of how much weight individuals had initially lost while on medication
Elevated Healthcare Standards : Our membership model transcends traditional healthcare approaches, raising the bar for quality and personalized care
& Egido, J
But certainly, many patients do achieve very high levels of weight loss
Designed to inhibit DPP-4, the enzyme found to degrade GLP-1 (7-37), this drug, generically called sitagliptin, was developed at Merck by its first research team solely led by women